Vaccinex Operating Expenses 2011-2025 | VCNX

Annual Operating Expenses Vaccinex

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	29 M	32.3 M	27 M	21 M	20.5 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
32.3 M	20.5 M	26 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Amphastar Pharmaceuticals AMPH	168 M	$ 25.27	-2.43 %	$ 1.22 B	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Arbutus Biopharma Corporation ABUS	96.2 M	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	92.7 M	$ 3.26	-3.12 %	$ 252 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Kamada Ltd. KMDA	69 K	$ 7.03	0.14 %	$ 260 M	Israel
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	338 M	$ 220.27	4.81 %	$ 5 B	Danmark
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Enlivex Therapeutics Ltd. ENLV	19.3 M	$ 0.91	-5.01 %	$ 18.7 M	Israel
Can-Fite BioPharma Ltd. CANF	14 M	$ 0.28	-2.28 %	$ 609 M	Israel
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.3	-3.51 %	$ 7.94 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
AstraZeneca PLC AZN	17.6 B	$ 89.78	-0.57 %	$ 96.9 B	Britain
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Anika Therapeutics ANIK	51.6 M	$ 9.57	0.84 %	$ 140 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Benitec Biopharma BNTC	9.83 M	$ 12.05	-7.06 %	$ 496 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.34	2.59 %	$ 14.7 M	USA
Nymox Pharmaceutical Corporation NYMX	11.7 M	-	-19.68 %	$ 18.4 M	Canada
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Aptorum Group Limited APM	20.7 M	$ 1.29	-3.01 %	$ 7.03 M	China
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Catalyst Biosciences CBIO	176 M	$ 14.01	-8.49 %	$ 922 M	USA
ChromaDex Corporation CDXC	53.9 M	-	-0.88 %	$ 598 M	USA
Axon Enterprise AXON	1.18 B	$ 566.18	-2.56 %	$ 42.9 B	USA
Cerus Corporation CERS	135 M	$ 2.16	0.47 %	$ 399 M	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Biogen BIIB	5.39 B	$ 174.42	1.11 %	$ 25.4 B	USA
BioVie BIVI	18.1 M	$ 1.42	-5.96 %	$ 2.1 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 27.36	-2.09 %	$ 1.76 M	USA
Cortexyme CRTX	34.6 M	-	-1.05 %	$ 67.1 M	USA
Cellectar Biosciences CLRB	15.3 M	$ 3.63	-3.97 %	$ 44.4 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 11.54	0.87 %	$ 746 M	USA